Article Information
History
- March 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Tsegahun Manyazewal1,*,
- Yimtubezinash Woldeamanuel1,
- Claire Oppenheim2,
- Asrat Hailu1,
- Mirutse Giday1,
- Girmay Medhin1,
- Anteneh Belete1,
- Getnet Yimer1,
- Asha Collins1,
- Eyasu Makonnen1 and
- Abebaw Fekadu1,3
- 1Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
- 2Department of Psychiatry, Boston University, School of Medicine, Boston, USA
- 3Global Health & Infection Department, Brighton and Sussex Medical School, Brighton, UK
- ↵*Address Correspondence: Tsegahun Manyazewal. tsegahunm{at}gmail.com, tsegahun.manyazewal{at}aau.edu.et. Addis Ababa University, College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), P.O. Box 9086, Addis Ababa, Ethiopia.